Inventor
FUMAGALLI TIZIANO
IT11 patents
⚠️ This page may combine multiple inventors who share the name “FUMAGALLI TIZIANO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SUPERNUS PHARMACEUTICALS INC
6 patentsUS8957206B2Feb 17, 2015
Methods of producing molindone and its salts
SUPERNUS PHARMACEUTICALS INC5 citations82
US11117862B2Sep 14, 2021
Methods of producing molindone and its salts
SUPERNUS PHARMACEUTICALS INC0 citations60
US10676432B2Jun 9, 2020
Methods of producing molindone and its salts
SUPERNUS PHARMACEUTICALS INC0 citations50
US10081595B2Sep 25, 2018
Methods of producing molindone and its salts
SUPERNUS PHARMACEUTICALS INC0 citations50
US9802893B2Oct 31, 2017
Methods of producing molindone and its salts
SUPERNUS PHARMACEUTICALS INC0 citations50
US9562011B2Feb 7, 2017
Methods of producing molindone and its salts
SUPERNUS PHARMACEUTICALS INC0 citations50
NERVIANO MEDICAL SCIENCES SRL
3 patentsUS9085565B2Jul 21, 2015
Process for the preparation of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide
NERVIANO MEDICAL SCIENCES SRL4 citations79
US9382235B2Jul 5, 2016
Unsolvated crystalline form 1 of N-[5-(3, 5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide and methods of use thereof
NERVIANO MEDICAL SCIENCES SRL3 citations68
US9649306B2May 16, 2017
Treatment of diseases through administration of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide
NERVIANO MEDICAL SCIENCES SRL0 citations48